New financing enables company to fulfill rising demand for single-use procedure kits for children with orthopedic issues WARSAW, Ind., Oct. 22, 2020 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a leader in...
Colson Medical, LLC is pleased to announce the merger of two Colson Medical companies, Acumed and OsteoMed. Operations will be integrated gradually over the coming year while maintaining both global...
CARLSBAD, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced...
During September, we attended many thought-provoking webinars and virtual events. These discussed the effects that COVID-19 has had on the life science industry, mergers and acquisitions (M&A) and investments. We’ve...
BELGRADE, Mont., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders,...
Avenu's Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic's Commitment to Improving Outcomes for Patients with End-Stage Renal Disease DUBLIN, Sept. 30, 2020 /PRNewswire/ -- Medtronic plc...
Kalamazoo, Michigan, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its...
PESSAC, France--(BUSINESS WIRE)--Hyprevention has raised new financing to support the V-STRUT© Vertebral Implant product. The financing will be used to execute the commercialization plans for the US spinal fracture market....
PETOSKEY, Mich.--(BUSINESS WIRE)--BioStar Capital, a value-add investment firm focused on transformational medical device technologies that serve unmet patient needs in cardiovascular and orthopedic medicine, today announced that Mark Toland, former...
Acquisition includes lead clinical-stage compound AT-1501, a next generation anti-CD40L antibody, in development for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases Senior management team with extensive drug development and...